Risk Factors at Chronic Non-communicable Diseases in People of Working Age
Launched by NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE · Feb 1, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Currently the emphasis in preventive medicine is also on health of the working population, which is a key state policy in the Russian Federation. Health of working citizens is an important factor in the development and safety of the production sector, but it is also the key to health and well-being of all other groups - children and older generations - that is, in fact, the fundamental factor for social development. Therefore, the integration of health-saving technologies into all areas of working life, including production and work activities, is particularly important. In today's world, i...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • employees of the company
- • persons without NCDs diagnosis and not receiving permanent medication
- • residents of the region of the Russian Federation where a factory with permanent or temporary registration is located
- Exclusion Criteria:
- • refusal to sign informed consent
- • any NCDs requiring constant medication
- • active cancer
- • pulmonary embolism
- • valve defects of the heart (except secondary mitral regurgitation)
About National Medical Research Center For Therapy And Preventive Medicine
The National Medical Research Center for Therapy and Preventive Medicine is a leading institution dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a focus on therapeutic interventions and preventive strategies, the center integrates cutting-edge scientific inquiry with practical applications to address a wide range of health conditions. Committed to excellence in research methodology and patient safety, the center collaborates with multidisciplinary teams to foster breakthroughs that contribute to the global medical community. Its mission emphasizes the importance of translating research findings into effective treatments that improve patient care and promote public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Olga Dzhioeva, MD, PhD
Study Director
National Medical Research Center for Therapy and Preventive Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported